Watch the shareholder vote on August 28. If approved, CRNX stock will converge to the deal price. The spread may narrow further as the closing date approaches. Any unexpected delay in the Australian waiting period or shareholder vote could create a brief arbitrage opportunity.
Price Chart
Executive Summary
Vertex's acquisition of Crinetics cleared all major antitrust hurdles: HSR waiting period expired August 12, and approvals from Austria, Germany, and Australia were received (Australia's waiting period expires August 27). The shareholder vote is scheduled for August 28, with closing expected in early September 2026. This removes a key regulatory risk and confirms the deal remains on track.
Key Facts
- HSR waiting period expired at 12:45 p.m. ET on August 12, 2026
- Antitrust approvals received from Austria, Germany, and Australia as of August 13, 2026
- Australian waiting period expires August 27, 2026 at 9:59 a.m. ET
- Shareholder special meeting set for August 28, 2026 to adopt merger
- Closing expected early September 2026
Financial Impact
No financial figures disclosed in this filing. Deal price was announced in prior Merger Agreement (July 6, 2026).
Risk Factors
- Shareholder vote may fail to adopt the merger
- Australian waiting period could be extended or challenged
- Other closing conditions may not be satisfied
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (CRNX) — Batch item 1 | 0001140361-26-032951 |
| Document: 0001140361-26-032951-index-headers.html | 0001140361-26-032951 |
| Document: 0001140361-26-032951-index.html | 0001140361-26-032951 |
| Document: 0001140361-26-032951.txt | 0001140361-26-032951 |
| 8-K Filing (CRNX) — Batch item 5 | 0001140361-26-032951 |
| Document: 0001140361-26-032951-index-headers.html | 0001140361-26-032951 |
| Document: 0001140361-26-032951-index.html | 0001140361-26-032951 |
| Document: 0001140361-26-032951.txt | 0001140361-26-032951 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 15-12G | — | awaiting T+1 | — | — |
Sep 1, 2026 4w ago | 25-NSE | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Sep 1, 2026 4w ago | 8-K | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Aug 14, 2026 7w ago | 8-K | $84.70 $84.75 | ▲ +0.06% | ▲ +0.53% | — |
Aug 3, 2026 8w ago | Press Release | $83.86 $84.00 | ▲ +0.17% | ▲ +0.37% | — |
Jul 10, 2026 12w ago | DEFA14A | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jul 10, 2026 12w ago | 8-K | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jun 30, 2026 13w ago | Press Release | $38.68 $42.23 | ▲ +9.18% | ▲ +9.31% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access